DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: BRIUMVI (ublituximab)
       *****************************************************
       #Post#: 3884--------------------------------------------------
       Briumvi (ublituximab) has FDA approval
       By: agate Date: December 29, 2022, 12:09 pm
       ---------------------------------------------------------
       An announcement from the MS Association of America (MSAA) about
       the FDA approval of ublituximab, also known now as Briumvi:
  HTML https://bit.ly/3i1pBL4
       #Post#: 3886--------------------------------------------------
       Re: Briumvi (ublituximab) has FDA approval
       By: agate Date: December 30, 2022, 1:56 pm
       ---------------------------------------------------------
       From MedPage Today (December 29, 2022)--"Anti-CD20 Agent Gains
       Approval for Multiple Sclerosis":
  HTML https://bit.ly/3GtuCW4
       #Post#: 3949--------------------------------------------------
       More on Briumvi (MS Foundation)
       By: agate Date: February 28, 2023, 8:31 pm
       ---------------------------------------------------------
       From the MS Foundation Focus on Research (February 28, 2023;
       January 11, 2023)--"FDA Approves New MS Injection Treatment":
  HTML https://msfocus.org/About-Us/MSF-News-Articles/2023/2377
       *****************************************************